Xanadu, a quantum computing company, has partnered with the University of Alberta to develop quantum algorithms for cancer therapy applications.
The collaboration will focus on using quantum computing to enhance radiotherapy treatment planning, with the goal of improving precision and reducing adverse side effects for patients. Researchers will explore how quantum algorithms can optimize dose distribution and tumor targeting in real time.
Quantum computing’s ability to process complex calculations at high speeds may provide advantages over classical methods in simulating biological systems and radiation interactions. The University of Alberta’s expertise in medical physics and oncology will complement Xanadu’s quantum hardware and software capabilities.
The project is part of a broader effort to apply quantum technology to healthcare challenges. While still in early stages, the partnership highlights the potential of quantum computing in precision medicine and personalized treatment strategies.
Xanadu, headquartered in Toronto, specializes in photonic quantum computing, while the University of Alberta is a leading research institution in Canada with a focus on medical applications of technology.
